Without making this post about life expectancy (the Washington Post had a great article about this recently ), were now dying of cancer, cardiovascular disease, hypertension, diabetes, obesity, car accidents, suicide, and opioid addiction
The SURMOUNT-1 trial showed average weight loss of 20.9% at the 15 mg dose, with 57% of participants losing more than 20% of body weight
Continued use, along with lifestyle changes, can help maintain weight loss and manage metabolic health over time.
Many patients find success with lower doses, especially if side effects make it hard to increase
Available at: (Accessed November 14, 2022)
Inno Shred GLP-1 is still just a supplement, yet it is priced similarly to programs that include lab work, real GLP-1 prescriptions, and ongoing medical care